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Amphipathic peptideThe twin-arginine translocase (Tat) system is used by many bacteria and plants to move folded proteins
across the cytoplasmic or thylakoidmembrane. Inmost bacteria, the TatA protein is believed to form a deﬁned
pore in the membrane through homo-oligomerization with other TatA protomers. The predicted secondary
structure of TatA includes a transmembrane helix, an amphipathic helix, and an unstructured C-terminal
region. Here biophysical and structural investigations were performed on a synthetic peptide representing the
amphipathic region of TatA (residues 22 to 44, abbreviated TatAH2). The C-terminal region of TatA (residues
44–89) was previously shown to be accessible from both the cytoplasmic and periplasmic sides of the
membrane only when the membrane potential was intact, suggesting dependence of its topology on an
energized membrane (Chan et al. 2007 Biochemistry 46: 7396–404). Such observation suggests that the
TatAH2 region would have unique lipid interactions that may be related to the function of TatA during
translocation and thus warranted further investigations. NMR and CD spectroscopy of TatAH2 show that it
adopts a predominantly helical structure in a membrane environment while remaining unstructured in
aqueous solution. Differential scanning calorimetry studies also reveal that TatAH2 interacts with DPPG lipids
but not with DPPC, suggesting that negatively charged phospholipid head groups contribute to themembrane
interactions with TatA.atAH2, TatA helix-2 peptide
lear magnetic resonance; CD,
try; DPPG, 1,2-dipalmitoyl-sn-
mitoyl-sn-glycero-3-phospho-
derived phosphatidylcholine;
derived phosphatidylethanol-
ilamellar vesicles; LUV, large
Sciences, University of Calgary,
el.: +1 403 220 4308; fax: +1
Molecular Biology, Faculty of
itish Columbia, Canada.
t as ﬁrst author.
l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
The twin-arginine translocase (Tat) system is used bymany bacteria
to move proteins across the cytoplasmic membrane. Tat substrates are
pre-folded in the cytoplasm and contain an S/TRRxFLK twin-arginine
motif in their N-terminal leader sequence. The Tat translocon consists of
the TatA, TatB, and TatC subunits. The current model identiﬁes TatA as
thepore subunit and theTatBC complex as the substrate recognition and
delivery vehicle (reviewed inNatale et al. [1]). Two other subunits, TatD
and TatE also exist but their roles are not understood and the translocon
seems to function properly in their absence.TatA is the smallest of the three functionally important Tat subunits
with a length of only 89 amino acids (in Escherichia coli) and the protein
is approximately 9.8 kDa. It is suggested to homo-oligomerize with
other TatA protomers to form a pore or channel in the cytoplasmic
membrane to allow passage of large, folded polypeptide substrates. The
protein is predicted to form two α-helices at the N-terminal half
followed by an unstructured C-terminal half, which was conﬁrmed by
circular dichroism (CD) spectroscopy [2]. Truncation studies show that
TatA can be shortened to 49 residues, by removing the C-terminal
region, and still participate in translocation [3]. Further investigations
reveal that a DDE acidic motif at residues 45 to 47 is essential for
translocation [4]. Mutagenesis studies have also identiﬁed many
important residues in both helices [3,5,6], further implicating these
two helices in translocation and formation of the channel. The ﬁrst helix
is highly hydrophobic and is presumed to be a transmembrane helix
whereas the secondhelix is amphipathic and is believed to lie parallel to
the cytoplasmic membrane. Protease and chemical accessibility exper-
iments showed that the entire C-terminal half immediately following
the secondhelix of TatAwas accessible fromboth the cytoplasm and the
periplasm, suggesting that this protein has dual topologies in the
membrane [7,8]. Therefore, it was suggested that TatA can be found in a
single transmembrane structure with helix-2 lying parallel to the
membrane or a double transmembranemodewith bothhelices inserted
into the membrane (Fig. 1). Interestingly, it appears that TatA can be
trapped in the single transmembrane topology when the membrane
Fig. 1. Dual topology models of TatA. Previous protease and chemical accessibility experiments demonstrate that the C-terminus of TatA is accessible from both the cytoplasm and
periplasm whereas the N-terminus was ﬁxed in the cytoplasm, suggesting that the C-terminal half of TatA has two topological states in the membrane [7,8]. Both single (left) and
double (right) transmembrane topologies were only detected when the proton motive force (PMF) was intact, whereas only the single transmembrane topology was detected when
the PMF was destroyed by a membrane uncoupler [8]. The C-terminal unstructured region following the two helices is not shown for simplicity.
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structural analysis of intact TatAd from Bacillus subtilis shows that it
has an ‘L’-shaped structure of a short ﬁrst helix with a turn to a longer
secondhelix [9,10], which supports the single transmembrane topology
model described in Fig. 1.
Here structural and biophysical investigations were carried out
with a synthetic peptide encompassing the second helix of E. coli TatA
(TatAH2) consisting of residues 22 to 44. NMR and CD spectroscopy
show that the helical structure of this amphipathic helix in TatA is
dependent on the presence of a stable membrane mimetic environ-
ment. Its similarities to helical cationic antimicrobial peptides led us
to evaluate its interaction with DPPG and DPPC phospholipids using
differential scanning calorimetry, and the results demonstrate that
TatAH2 associates with negatively charged lipids while having little
effect on zwitterionic bilayers.
2. Materials and methods
2.1. Materials
The TatAH2 peptide was commercially synthesized to 95% purity
(Invitrogen Custom Services). All phospholipids and dodecylphospho-
choline (DPC) were purchased from Avanti Polar Lipids, Inc. (Alabaster,
AL) as stock solutions dissolved in chloroform. D2O was obtained from
CDN Isotopes (Pointe-Claire, Quebec, Canada), deuterated sodium
dodecyl sulfate (SDS) and 2,2-dimethyl-2-silapentane-5-sulfonic acid
(DSS)was obtained fromCambridge Isotope Laboratories Inc. (Andover,
MA). Spectroscopic grade SDS and all other reagents were purchased
from Sigma-Aldrich (Oakville, Ontario, Canada). The lipid concentra-
tions in the small unilamellar vesicle (SUV) samples were determined
by measuring the phosphate concentration according to the assay
described by Ames [11].
2.2. Circular dichroism spectroscopy
CD spectra were recorded with a J810 spectropolarimeter (Jasco)
from 260 to 190 nmwith a 1 nm bandwith, 0.5 nmpitch at 50 nm/min
in a 1 mm quartz cuvette (Hellma). Experiments were done with a
ﬁnal peptide concentration of 40 μM in 25 mM phosphate buffer (pH
7.4), 50% v/v triﬂuoroethanol, SUVs composed of E. coli polar lipids,
and 30 mM SDS or DPC micelles. The structure of TatAH2 was also
monitored by titrating eggPC or eggPG SUVs into a solution of peptide.
Brieﬂy, a 200 μl solution of 50 μM peptide was prepared in buffer and
spectra were acquired as described above. An aliquot of 10 μl eggPC oreggPG SUVs (lipid concentration 2.25 mM) was added to the cuvette
and another spectrumwas collected. A total of ten 10 μl aliquots were
added to the peptide sample with a spectrum acquired after each
addition.
2.3. Differential scanning calorimetry
TatAH2was dissolved in 3:1methanol:chloroform andmixedwith
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) or 1,2-dipalmi-
toyl-sn-glycero-3-phospho-(1′-rac-glycerol) (DPPG) at a 1:100 pep-
tide-to-lipid ratio. The organic solvent was evaporated in a stream of
N2 gas and placed under vacuum for ~2 h to generate lipid ﬁlms. Pure
lipid ﬁlms were prepared in a similar fashion to a ﬁnal concentration
of 0.5 mg/ml. The ﬁlms were resuspended in buffer (20 mM
phosphate, 130 mM NaCl, pH 7.4) at 60 °C and vortexed vigorously.
The lipid suspension was incubated at 60 °C for an additional 5 min
and vortexed again. Data was collected on a Microcal VP-DSC
instrument and the resulting thermograms were analyzed in Origin
(version 7). A total of four scans were acquired between 20 and 60 °C
using a scan rate of 10 °C/h. The calorimeter cells were passively
cooled between heating scans. The thermogram from the fourth scan
was used in the ﬁnal analysis.
2.4. Calcein leakage
Calcein leakage experiments were performed according to the
protocol described by Matsuzaki et al. [12]. Brieﬂy, lipid ﬁlms
composed of 1:1 mixtures of eggPE:eggPG lipids were prepared
from stock solutions dissolved in chloroform. The organic solvent was
evaporated in a stream of N2 gas followed by exposure to vacuum for
2 h. The lipid ﬁlms were then resuspended in buffer (10 mM Tris,
150 mM NaCl, 1 mM EDTA, pH 7.4) containing 70 mM calcein. This
lipid suspension was subjected to 5 cycles of liquid nitrogen freezing
and thawing under warm water, followed by 15 passes through two
0.1 μM polycarbonate ﬁlters using a mini-extruder apparatus (Avanti
Polar Lipids). The calcein encapsulated LUVs were separated from free
calcein using a Sephadex G50 gel ﬁltration column. The percentage of
calcein released from the calcein LUVs was followed using a Varian
Cary Eclipse Fluorimeter (Varian Inc. Palo Alto, CA). Calcein containing
LUVs were added to a ﬁnal lipid concentration of 10 μM and the
ﬂuorescence emission intensity at 520 nm (excitation 490 nm) was
monitored. Once the ﬂuorescence reading stabilized, peptide was
added to a ﬁnal concentration of 1 μM. To establish 100% leakage, 20 μl
Fig. 2. CD spectra of TatAH2 peptides in various environments. Spectra were recorded in
25 mM phosphate buffer (pH 7.4), 0.25 and 1 mM E. coli polar lipid small unilamellar
vesicles (SUV), 50% v/v triﬂuoroethanol (TFE), and 30 mM SDS or DPC micelles. All
spectra were collected at 25 °C.
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solubilize the LUVs and release all of the calcein.
2.5. Nuclear magnetic resonance spectroscopy
An aqueous sample of TatAH2 peptide was prepared in a 9:1
mixture of H2O:D2O to a ﬁnal concentration of 1.43 mM and a pH of
3.46. 2,2-Dimethyl-2-silapentane-5-sulfonic acid was added as an
internal chemical shift standard to a ﬁnal concentration of 0.2 mM.
Two-dimensional NOESY spectra were collected (see below) and then
deuterated SDS was added to this sample to a ﬁnal concentration of
200 mM and a ﬁnal pH of 4.32. In an attempt to improve spectral
resolution, NaCl was also added to this sample to a ﬁnal concentration
of 100 mM.
Two-dimensional 1H NOESY spectra (Bruker pulse sequence
noesyesgpph) were recorded at 25 °C for the aqueous TatAH2 sample
on a Bruker Avance 600 MHz spectrometer using a mixing time of
250 μs. For samples containing SDS micelles, 2D 1H NOESY spectra
were acquired at 25, 30 and 37 °C on a Bruker Avance 700 MHz
spectrometer using a mixing time of 100 μs. To facilitate analysis, 2D
TOCSY and COSY spectra (pulse programs mlevesgpph and cosyd-
fesgpph respectively) were also acquired for the SDS bound peptide
samples. A mixing time of 120 μs was used in the TOCSY experiment.
Spectra from the 600 MHz spectrometer were obtained with
4096×512 data points in the F2 and F1 dimensions and a sweep
width of 8503.401 Hz. Spectra from the 700 MHz spectrometer were
obtained with 4096×600 data points in the F2 and F1 dimensions and
a sweepwidth of 8992.806 Hz.Water suppression was achieved using
excitation sculpting [13]. All spectra were zero-ﬁlled and multiplied
by a shifted sine-bell curve using the NMRPipe software package [14].
Spectra were analyzed using NMRView 5.2.2.1 [15] with all spectra
referenced to the DSS internal standard at 0.00 ppm. Proton chemical
shifts were assigned according to Wüthrich [16]. Extended peptide
structures were generated by CNS [17] and used as startingmodels for
the structure calculations. Dihedral angle restraints were placed upon
the backbone angles of non-glycine residues, thereby restricting these
to allowed regions of the Ramachandran plot [18]. An ensemble of
peptide structures was calculated based on the unambiguous and
ambiguous NOE restraints determined from the 2D-NOESY spectra
using ARIA (Ambiguous Restraints for Iterative Assignment) version
1.2 [19]. In the ﬁnal ARIA analysis, nine iterations were performed
with 20 structures calculated in the ﬁrst seven iterations, 40
structures in the eighth iteration and 100 structures were generated
in the ninth iteration. The 20 lowest energy structures from the ﬁnal
iteration were kept and analyzed.
3. Results
3.1. Secondary structure of TatAH2
Previous CD experiments with a truncation mutant consisting of
helix-2 and the remaining C-terminal region of TatA (residues 20–89)
showed that it is mostly unstructured in solution with a slight
increase of helical content in the presence of liposomes [2]. Here we
focused exclusively on the helix-2 region as previous results may have
been dominated by contributions to the CD spectra from the large C-
terminal region of TatA that is unstructured. Using a synthetic peptide
consisting of residues 22 to 44 (NH2-TKKLGSIGSDLGASIKGFKKAMS-
COO−) of E. coli TatA, the secondary structure of this region of TatA
was investigated in various environments. A far-UV CD spectrum of
TatAH2 showed that the peptide is relatively unstructured in aqueous
buffer and with a low concentration (0.25 mM lipid) of small
unilamellar vesicles (SUVs) made of E. coli polar lipids. However,
the shape of the CD spectra in the presence of SUVs is not identical to
that of the peptide in buffer, suggesting a slight difference in its
secondary structure. In the presence of higher concentration E. coliSUVs, DPC and SDS micelles, and 50% triﬂuoroethanol, the CD spectra
change to what is highly indicative of α-helical structure (Fig. 2). The
vesicles generated at the low 0.25 mM lipid concentration are likely
unstable and may contribute to the lack of secondary structure
observed for TatAH2. These observations suggest that the peptide is
mostly unstructured in aqueous solution, but that it adopts a helical
structure when placed in a membrane mimetic environment such as
stable SUVs or detergent micelles.
In contrast, a synthetic peptide representing the C-terminal region
(residues 44 to 89 of TatA), displayed a lack of secondary structure
with all these membrane mimetics except in the presence of SDS,
which showed induction of some helical structure (Supplementary
Fig. 1).
3.2. Interactions of TatAH2 with lipids
Given the amphipathicity of the TatAH2 helix, it harbors
considerable similarities to many helical cationic antimicrobial
peptides [20,21]. This suggests that we could learn more about the
TatA mechanism of action by performing experiments traditionally
used to study antimicrobial peptides. Differential scanning calorim-
etry (DSC) has been used extensively to study phase transitions of
lipid bilayers where the difference in heat required to increase the
temperature of the lipid sample is measured in the presence or
absence of the peptide [22,23]. Changes in phase transitions with
respect to different peptide-to-lipid ratios allow one to discern
whether interactions are occurring and determine the nature of the
interaction [24,25]. DPPC lipid suspensions in the absence and
presence of 10:1 lipid-to-peptide were heated from 20 to 60 °C and
measured by DSC. TatAH2 did not appear to have any effect on the
phase transition of this zwitterionic lipid bilayer (Fig. 3A). The same
experiments performed with DPPG lipids show that the addition of
the peptide affects the 31.8 °C pre-transition, causing a decrease in the
area of the peak (Fig. 3B inset). Themain phase transition of DPPGwas
also affected where the transition for the pure lipid at 40.2 °C
broadened and separated into two slightly overlapping peaks at 39.9
and 41.1 °C in the presence of peptide (Fig. 3B). This suggests that
there are two different states of the lipid molecules, one in which the
main phase transition is stabilized (higher temperature peak) and one
in which themain phase transition is destabilized (lower temperature
transition). This can be attributed to the presence of two different
lipid populations, one of which is peptide-rich and one that is peptide-
poor. The peptide-rich lipids likely arise from the cationic peptide
sequestering the negatively charged lipids through electrostatic
interactions. Unfortunately, it is impossible to distinguish which
transition corresponds to each lipid population based on these results
Fig. 3. DSC thermograms of TatAH2 mixed with DPPC (panel A) or DPPG (panel B).
Samples containing peptide (gray) at a 10:1 lipid:peptide ratio are compared to the
thermograms of pure lipid suspensions (black). An expanded view of the pre-transition
region for each lipid is shown as insets. The ﬁnal scan of four consecutive scans is
shown. The structure of the TatAH2 peptide was also monitored using CD spectroscopy
by adding increasing amounts of SUVs composed of either eggPC (black) or eggPG
(gray) phospholipids (panel C). Shown is the absolute change in average CD signal (in
mdeg) between 220 and 225 nm compared to the average CD values obtained in the
absence of lipid (see Supplementary Fig. 2). Error bars represent the standard deviation
of the average CD intensities between 220 and 225 nm.DSC thermograms of TatAH2
mixed with DPPC (panel A) or DPPG (panel B). Samples containing peptide (gray) at a
10:1 lipid:peptide ratio are compared to the thermograms of pure lipid suspensions
(black). An expanded view of the pre-transition region for each lipid is shown as insets.
The ﬁnal scan of four consecutive scans is shown.
Fig. 4. Calcein leakage from eggPE:eggPG LUVs. The addition of TatAH2 to the LUVs did
not induce any signiﬁcant leakage from the vesicles, similar to the results seen when
buffer alone was added. The C-terminal amphipathic helix of the human macrophage
inﬂammatory protein-3α (mip3a) was used as a positive control to demonstrate
peptide induced calcein leakage from LUVs.
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negatively charged lipid bilayers and it is tempting to suggest that this
interaction plays a role in the oligomerization of TatA into pores in the
E. coli membranes.
Given the above observations that TatH2 associates with nega-
tively charged lipids, its secondary structure was evaluated in the
presence of SUVs composed of eggPG or eggPC using CD spectroscopy.
In agreement with the other negatively charged lipid environments,
TatAH2 adopts an alpha helical conformation in the presence ofnegatively charged eggPG lipids. However, the SUVs made with
zwitterionic eggPC lipids did not induce any large conformational
change in the peptide (Supplementary Fig. 2). Titrations with the
SUVs demonstrate that at a lipid concentration as low as 0.1 mM, the
negatively charged lipids induced a signiﬁcant conformational
change, whereas little effect was observed with eggPC SUVs at all of
the lipid concentrations tested (Fig. 3C). These results are in
agreement with the interactions observed by DSC, suggesting that
TatH2 preferentially interacts with negatively charged lipid species.
Peptide-induced leakage of calcein dye encapsulated in large
unilamellar vesicles (LUVs) has been used to examine the membrane
destabilizing properties of many antimicrobial peptides [26]. To
examine the potential membrane perturbing properties of TatAH2,
calcein dye-encapsulated LUVs consisting of 1:1 eggPG-to-eggPEwere
tested for their ability to release calcein dye as described by Schibli et
al. [27]. Even at a lipid-to-peptide molar ratio of 10:1, the addition of
TatAH2 did not result in any discernable increase in ﬂuorescence
intensity (Fig. 4). On the other hand, a strong leakage-inducing
peptide, mip3α [28], induces approximately 70% release of calcein dye
from the LUVs. This suggests that the TatAH2 peptide, unlike many
antimicrobial peptides, is incapable of forming pores in membranes
on its own.3.3. Solution structure of TatAH2
The two-dimensional NOESY spectrum of TatAH2 in aqueous
solution did not indicate the presence of a well deﬁned peptide
structure due to the lack of observable inter-residue nOe cross peaks,
poor peak dispersion, and a low number of peaks in general (not
shown). This demonstrates that TatAH2 is essentially unstructured in
water, consistent with the results from the CD experiments in
aqueous buffer. Additional TatAH2 samples were also prepared in
50% v/v triﬂuoroethanol and in a co-solvent mixture of 4:4:1 CDCl3:
methanol-d3:H2O but these samples did not yield NMR spectra
suitable for detailed structural analysis (data not shown), despite the
fact that these two co-solvents have been successfully used to study
other amphipathic helical peptides [29,30].
Spectra for the peptide in the presence of SDS micelles were
acquired at 25, 30, and 37 °C on a 600 and 700 MHz spectrometer to
obtain fully resolved cross-peaks. The ﬁnal conditions yielding well
resolved spectra were 1.43 mM peptide in 200 mM SDS, 100 mMNaCl
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TatAH2 bound to SDS micelles at 37 °C is shown in Fig. 6. The peptide
adopts a predominantly helical conformation consistent with the
structural motif suggested by CD spectroscopy. Even though structure
calculations based on the NOESY spectra at 25 and 30 °C were
complicated by signiﬁcant spectral overlap, the chemical shift index of
the TatAH2 Cα protons suggests that the helical peptide conformation
is conserved at lower temperatures (Supplementary Fig. 4). By ﬁtting
the 20 lowest energy structures across residues Ser27 to Phe39
(numbered according to the full-length sequence), the ﬁnal structure
has a backbone RMSD of 0.785 Å (Fig. 6A). The helix formed by
TatAH2 in the presence of SDS micelles is largely amphipathic with
many of the large hydrophobic residues appearing on the same face of
the helix while the opposite face contains the hydrophilic residues
(Fig. 6B and C). A table with relevant statistics from the ARIA structure
calculations is shown in Supplementary Table 1.
4. Discussion
The dual topology models of TatA suggested previously provide
additional clues towards the translocation mechanism by Tat [7,8]. The
original model, accepted by most, consists of an L-shaped conformation
with the hydrophobic helix-1 traversing the membrane and amphi-
pathic helix-2 lying along the plane of the membrane (Fig. 1, left). This
model was recently conﬁrmed by NMR spectroscopy of TatAd from B.
subtilis [9]. The secondmodel consists of a double transmembrane helix
structure with both helices inserted into the membrane (Fig. 1, right).
This suggestion was somewhat surprising, but conceivable due to the
rationale that the translocating pore (and possibly the substrate)would
be ‘solvated’ by the polar residues of helix-2. The second model wouldFig. 5. Representative region of the 2D NOESY spectra of TatA H2 in 200 mM SDS and 100 mM
(i) and αH (i-1) protons is shown.imply that helix-2 of TatA can insert into the bilayer to form a
transmembrane helix. More importantly, the dual topologies suggest
that unique interactions between helix-2 in addition to those with the
substratemust also exist andmay be important for translocon assembly
and/or translocation. These interactions were investigated through
biophysical and structural experiments targeted at this particular region
of E. coli TatA.
A combination of DSC and CD experiments show interesting effects
of lipid head groups on peptide structure, which then results in
peptide-lipid associations that perturb the lipid phase transition due
to head group domain clustering. This is supported by the observation
that PG affects the secondary structure of TatAH2 but PC does not and
TatAH2 affects the phase transition of DPPG but not DPPC. Although
the structure of this peptide is analogous to many amphipathic
antimicrobial peptides withmembrane perturbing properties, TatAH2
does not appear to act on lipid bilayers in the samemanner. The effect
of TatAH2 on DPPG bilayers showed a unique perturbation in themain
phase transition peak. This change suggests the presence of a peptide-
rich lipid population and a peptide-poor or peptide-free lipid popula-
tion that complicates our efforts in determining the exact manner of
interaction. Furthermore, membrane partitioning of TatAH2 may be
weaker under the circumstances tested here, possibly requiring the
aid of helix-1. Nevertheless, the DSC measurements clearly suggest
that peptide-mediated lipid domain clustering with DPPG is occurring.
TatAH2 appeared to have no signiﬁcant effect on DPPC multi-
lamellar lipid suspensions based on the DSC results, an observation
that suggests there is little interaction between the peptide and these
lipids. A possible explanation for this observation could be provided
by the recent NMR structure of full-length B. subtilis TatAd solved in
the presence of DPC detergent micelles [9]. This structure displaysNaCl collected on a 700 MHz spectrometer at 37 °C. The connectivity between the NH
Fig. 6. Solution structure of TatAH2 bound to SDS micelles at 37 °C. A. Backbone overlay of the 20 lowest energy structures of micelle bound TatAH2. B. The backbone atoms are ﬁt
across the 6th to 18th residues and have an RMSD of 0.785 Å. The peptide adopts a fairly well deﬁned helical conformation between Ser27 and Phe39 (numbered according to the full
sequence). The other side chains are indicated as follows: Lys in blue, Asp in red, Thr and Ser in magenta, and Met in green. C. Hydrostatic surface model of TatAH2. This helix is
largely amphipathic with the hydrophobic side chains (gray) appearing on one face of the peptide. The location of Phe39 is indicated to orient the reader. Basic residues are colored
blue and acidic red.
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therefore we could postulate that TatAH2 lying parallel to the lipid
has little effect on the phase transition. On this note, we should also
keep in mind that choline head groups are not typically found in
bacterial cytoplasmic membranes (reviewed in Ref. [31]), and as such
choline-containing lipids or micelles may not be a true representation
with respect to the interactions between TatA and negatively charged
bacterial membranes. This is supported by observations that lipid
composition is important for membrane protein topogenesis, assem-
bly, stability, transport, and activity (reviewed by Schneiter and
Toulmay [32]).
The differences observed with the charged DPPG and zwitterionic
DPPC lipids suggest that TatAH2 does not partition into the
hydrophobic core of the DPPC bilayer while an electrostatic attraction
with the negatively charged head groups of DPPG phospholipids
promotes membrane partitioning. Another recent study using solid-
state NMR determined the membrane alignment of B. subtilis TatAd
[10]. The best-ﬁtting simulations of the NMR data showed that thetwo helices were tilted with respect to the membrane bilayer, with
the amphipathic second helix not entirely parallel to the membrane
but tilted either 64° or 116° from the perpendicular axis. These
structures were determined using bicelles of mixtures containing 80%
PC and 20% PG and in combination with the DSC observations seen
here it is possible that the tilted amphipathic helix observed in the
above study is attributed to interactions with the PG head groups. We
have suggested that the limitation of our work is due to the
requirement of the transmembrane ﬁrst helix for stronger perturba-
tions of DPPG bilayers, the above study supports this as the tilting
amphipathic helix could be an indication of a weaker interaction not
allowing for full insertion of the helix.
The NMR structure of TatAH2 from E. coli shows that it forms a
short alpha-helix with ﬂexible ends. The ﬂexibility may be due to the
absence of the two other portions of TatA that are normally attached
to the ends of this peptide. The structure of TatAd from B. subtilis was
solved for the full protein containing additional residues that stabilize
the orientation of both helices and showed that the ends of its second
2295C.S. Chan et al. / Biochimica et Biophysica Acta 1808 (2011) 2289–2296helix are far less ﬂexible [9]. Since our structure was solved with only
a portion of TatA, it is difﬁcult to draw immediate comparisons to the
B. subtilis structure. However, it should be noted that the Tat system
from Gram positive bacteria such as B. subtilis, is a minimal system
consisting of only TatAd and TatCd. TatAd is strongly suggested to be
involved in both substrate recognition as well as forming the
translocating pore [33,34]. On the other hand, TatA from Gram
negative bacteria appears to be strictly involved in pore formation,
and the TatBC complex is responsible for substrate recognition.
Furthermore, the hypothesis that TatA from Gram positive bacteria
ﬁrst surrounds the substrate in the cytoplasm and then inserts into
the membrane to allow translocation suggests that helix-2 of the
Gram positive TatA may play a completely different role from the
same region in the Gram negative protein we have studied here
[33,35].
The amphipathic structure of TatAH2 bound to SDS micelles is
reminiscent of the solution structures of many membrane-associated
cationic antimicrobial peptides. The amphipathic helix is a common
structural motif for antimicrobial peptides and many mechanisms of
action for these peptides are predicated on the idea that these
amphipathic molecules insert into the interfacial region of a
phospholipid bilayer and destabilize the bacterial membrane
[23,36–38]. In all of these models the hydrophobic residues penetrate
into the hydrophobic core of the membrane while the positively
charged residues interact with the lipid head groups. While it is
apparent that TatAH2 is incapable of self-associating into membrane
pores on its own, it is likely that this peptide resides at the interfacial
region of a negatively charged membrane. Further work is required to
understand the molecular organization of TatA in E. coli membranes.
A unique feature of TatAH2 is that it contains only one acidic
aspartate residue in its sequence and it is situated near the center of the
helix (Fig. 6B and C). The remaining acidic residues in full-length TatA
follow this helix at positions 45 to 47. All four residues are highly
conserved in Gram negative bacteria and have been shown to be
important for translocation via mutagenesis studies [4,6]. The corre-
sponding helix from B. subtilis has three glutamate residues, one at each
endof thehelix andonenear the center as seen inourE. coli structure [9].
Given prior observations that the dual topology of TatA and in vitro
translocation appears to be dependent on an intactmembrane potential
[8,39], one or several of these acidic residues may serve as the ‘gate
switch’ for translocation of the substrate, assuming that our previous
hypothesis that the protein conducting channel is lined by the polar face
of helix-2 in a double transmembranehelixmodel. It is apparent that the
role of Asp31 is only important for translocation and not TatA self-
assembly as mutation of this residue had no effect on the formation of
tube-like structures in the cell [40]. Furthermore, helix-2 may also be
important for stabilizing helix-1 as a synthetic peptide corresponding to
helix-1 was insoluble in most aqueous solvents and NMR samples
containing 50% TFE or SDS yielded NMR spectra thatwere not amenable
to structure calculations (data not shown).
5. Conclusions
This study provides some new insight into the translocation
mechanism of TatA. By focusing our attention on the amphipathic
helix-2 that appears to be important for translocation, not only do we
demonstrate its structural dependence on membrane mimetic
environments, but we also identify interesting lipid-peptide in-
teractions that may be important for TatA assembly and/or function.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamem.2011.05.024.
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